Verified email-pattern data for Aspidia is currently limited. You can still use the company insights and contact sections below.
ASPIDIA srl is an innovative biotech startup committed to the design, management, and development of scientific research projects regarding (i) the bioremediation of pollutants through the use of recombinant enzymes and (ii) the use of probiotics as vectors for the presentation of antibodies and/or antigens on mucosal surfaces.
ASPIDIA offers chemical industries a service for research, optimization and production of enzymes for industrial processes, including bioremediation.
Bioremediation, which involves the use of a biological agent to degrade contaminants, is an environmentally friendly and sustainable approach that can destroy a pollutant or convert harmful contaminants into harmless substances. It could effectively and economically combat contamination by various pollutants, including per- and polyfluoroalkyl substances (PFASs) in environmental matrices. Because the ability of biological agents to degrade PFASs is still poorly studied, we are conducting research to find the most appropriate enzyme(s) and optimize them for specific needs.
ASPIDIA, in collaboration with key partners, uses a range of advanced methodologies, including bioinformatics analysis and in silico modeling, combined with advanced microbiological techniques for custom optimization of novel bioremediation and transformation processes for specific industrial needs.
By identifying enzymes tailored to specific industrial processes, a reduction in operating costs and the implementation of sustainable, green infrastructure at limited fixed costs can be achieved.
In addition, ASPIDIA, together with a key partner, is conducting scientific research on the use of probiotics as vectors for antigen presentation on mucosal surfaces. This research is intended to be a proof-of-principle on a possible new vaccine against COVID-19, but once conditions are established and optimized, the results of the research could allow the same technology to be used for other antigens and even monoclonal antibodies.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Milan, Mi 20100, It
- Industry
- Biotechnology Research
- Website
- https://www.aspidia.com/
- HQ
- Milan, MI
Aspidia Questions
ASPIDIA's website is https://www.aspidia.com/
ASPIDIA's LinkedIn profile is https://it.linkedin.com/company/aspidia
ASPIDIA has
2 employees.
View email and phone details for 2
employees at ASPIDIA.
ASPIDIA's industry is
Biotechnology Research
ASPIDIA's top competitors are
Fondazione Irccs Istituto Nazionale Dei Tumori,
In&valid,
Loki - Laboratory Of Key Innovations,
Email Genius,
Myconic,
Popup S.r.l,
Komugi,
Arkady,
K•hero,
Matricis.ai.
ASPIDIA's categories are Biotechnology Research
ASPIDIA's founding year is 2021
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.